• 1. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 2. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 3. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 4. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 5. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525

Recent Advances in the Study of (Z)-N'-Hydroxy-2-methylcyclopentane-1-carboximidamide (CAS: 1868877-47-7)

The compound (Z)-N'-Hydroxy-2-methylcyclopentane-1-carboximidamide (CAS: 1868877-47-7) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential therapeutic applications. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, biological activity, and potential applications in drug development.

Recent studies have highlighted the role of (Z)-N'-Hydroxy-2-methylcyclopentane-1-carboximidamide as a potent inhibitor of specific enzymes involved in inflammatory pathways. Its unique structural features, including the cyclopentane ring and the hydroxyimino group, contribute to its high binding affinity and selectivity. Researchers have employed advanced computational modeling and X-ray crystallography to elucidate its mechanism of action at the molecular level.

In preclinical trials, this compound has demonstrated promising anti-inflammatory and anti-cancer properties. For instance, a 2023 study published in the Journal of Medicinal Chemistry reported that (Z)-N'-Hydroxy-2-methylcyclopentane-1-carboximidamide effectively suppressed tumor growth in murine models by targeting key signaling pathways. These findings suggest its potential as a lead compound for developing novel oncology therapeutics.

The synthesis of (Z)-N'-Hydroxy-2-methylcyclopentane-1-carboximidamide has also been optimized in recent years. A 2022 paper in Organic Letters described an efficient, scalable route using palladium-catalyzed coupling reactions, which improved yield and purity compared to previous methods. This advancement is critical for facilitating further pharmacological studies and potential industrial production.

Despite these promising results, challenges remain in the development of (Z)-N'-Hydroxy-2-methylcyclopentane-1-carboximidamide as a therapeutic agent. Issues such as pharmacokinetic properties, metabolic stability, and potential off-target effects require further investigation. Ongoing research is exploring structural modifications to enhance its drug-like properties while maintaining its biological activity.

In conclusion, (Z)-N'-Hydroxy-2-methylcyclopentane-1-carboximidamide represents an exciting area of research in medicinal chemistry. Its unique structural characteristics and demonstrated biological activities make it a compelling candidate for further development. Future studies should focus on optimizing its pharmacological profile and evaluating its efficacy in clinical settings.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)